Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling - PubMed (original) (raw)
Comparative Study
. 2006 Oct 12;25(47):6277-90.
doi: 10.1038/sj.onc.1209645. Epub 2006 May 15.
Affiliations
- PMID: 16702957
- DOI: 10.1038/sj.onc.1209645
Comparative Study
Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling
M Marderosian et al. Oncogene. 2006.
Abstract
The differential expression of the critical cell cycle control proteins cyclin D1 and c-myc has been shown to result in Akt-dependent hypersensitivity of tumor cells to mTOR inhibitors. We have previously demonstrated that the differential utilization of internal ribosome entry sites within the mRNAs of these transcripts allows maintenance of protein synthesis in the face of rapamycin (rapa) exposure in an Akt-dependent manner. Here, we demonstrate that in addition to this mechanism, cyclin D1 and c-myc mRNA stability is also coordinately regulated following rapa treatment depending on Akt activity status. We identify A/U-rich response elements within the 3' untranslated regions (UTRs) of these transcripts, which confer the observed differential stabilities and show that the RNA-binding protein, tristetraprolin (TTP), interacts with these elements. We also present evidence that TTP accumulates in response to rapa exposure, binds to the cis-acting elements within the cyclin D1 and c-myc 3' UTRs and is differentially serine phosphorylated in an Akt-dependent manner. Furthermore, the differential phosphorylation status of TTP results in its sequestration by 14-3-3 proteins in quiescent Akt-containing cells. Finally, siRNA-mediated knockdown of TTP expression or inhibiting a known regulator of TTP phosphorylation, p38 MAP kinase, abolishes the effects on cyclin D1 and c-myc mRNA stability. We assume that the differential control of cyclin D1 and c-myc mRNA stability and translational efficiency constitutes a coordinate response to rapa contributing to the maintenance of expression of these determinants in rapa-resistant quiescent Akt-containing cells following exposure.
Similar articles
- Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway.
Shi Y, Sharma A, Wu H, Lichtenstein A, Gera J. Shi Y, et al. J Biol Chem. 2005 Mar 25;280(12):10964-73. doi: 10.1074/jbc.M407874200. Epub 2005 Jan 4. J Biol Chem. 2005. PMID: 15634685 - AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.
Vartanian R, Masri J, Martin J, Cloninger C, Holmes B, Artinian N, Funk A, Ruegg T, Gera J. Vartanian R, et al. Mol Cancer Res. 2011 Jan;9(1):115-30. doi: 10.1158/1541-7786.MCR-10-0105. Epub 2010 Dec 6. Mol Cancer Res. 2011. PMID: 21135252 Free PMC article. - Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling.
Jo OD, Martin J, Bernath A, Masri J, Lichtenstein A, Gera J. Jo OD, et al. J Biol Chem. 2008 Aug 22;283(34):23274-87. doi: 10.1074/jbc.M801185200. Epub 2008 Jun 18. J Biol Chem. 2008. PMID: 18562319 Free PMC article. - MAPK p38 regulates inflammatory gene expression via tristetraprolin: Doing good by stealth.
O'Neil JD, Ammit AJ, Clark AR. O'Neil JD, et al. Int J Biochem Cell Biol. 2018 Jan;94:6-9. doi: 10.1016/j.biocel.2017.11.003. Epub 2017 Nov 8. Int J Biochem Cell Biol. 2018. PMID: 29128684 Free PMC article. Review.
Cited by
- MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation.
Li Y, Challagundla KB, Sun XX, Zhang Q, Dai MS. Li Y, et al. Oncotarget. 2015 Jan 20;6(2):1101-14. doi: 10.18632/oncotarget.2728. Oncotarget. 2015. PMID: 25544755 Free PMC article. - AGO-RBP crosstalk on target mRNAs: Implications in miRNA-guided gene silencing and cancer.
Kakumani PK. Kakumani PK. Transl Oncol. 2022 Jul;21:101434. doi: 10.1016/j.tranon.2022.101434. Epub 2022 Apr 26. Transl Oncol. 2022. PMID: 35477066 Free PMC article. Review. - Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.
Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, Pagès G. Essafi-Benkhadir K, et al. Mol Biol Cell. 2007 Nov;18(11):4648-58. doi: 10.1091/mbc.e07-06-0570. Epub 2007 Sep 12. Mol Biol Cell. 2007. PMID: 17855506 Free PMC article. - Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells.
Chamboredon S, Ciais D, Desroches-Castan A, Savi P, Bono F, Feige JJ, Cherradi N. Chamboredon S, et al. Mol Biol Cell. 2011 Sep;22(18):3366-78. doi: 10.1091/mbc.E10-07-0617. Epub 2011 Jul 20. Mol Biol Cell. 2011. PMID: 21775632 Free PMC article. - ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner.
Suk FM, Chang CC, Lin RJ, Lin SY, Liu SC, Jau CF, Liang YC. Suk FM, et al. Sci Rep. 2018 Feb 9;8(1):2742. doi: 10.1038/s41598-018-21160-z. Sci Rep. 2018. PMID: 29426877 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous